Dr. Matt Terra is one of three infectious disease specialists on the Extremities at Risk team.  After earning his undergraduate degree magna cum laude and medical degree from Georgetown University, he completed his postgraduate residency in internal medicine and infectious diseases fellowship at the University of Colorado.  

Infectious Disease Consultants, P.C.
1601 E. 19th Avenue, Suite 3650
Denver, Colorado 80218
PH: 303-831-4774  FAX: 303-839-7750  

American Board of Internal Medicine, Diplomate, 1998

American Board of Internal Medicine, Diplomate Infectious Disease, 2000

Colorado State License, 2005

DEA Certification, 2006

Magna Cum Laude, 1991 Phi Beta Kappa, 1991

Alpha Sigma Nu Honor Society, 1991

1.  Six-month Intermittent Directly Observed Therapy for Isoniazid-Resistant Tuberculosis. Poster presentation at the Annual Conference of the American thoracic Society, San Francisco CA, May 18-23, 2001.

2.  Streptomycin vs. Ethambutol as the 4th Drug in Highly Intermittent, Directly Observed Tuberculosis Treatment. Poster presentation at the Annual Conference of the American thoracic Society, San Francisco CA, May 18-23, 2001.

3.  Incidence and Severity of Hepatotoxicity During Tuberculosis Treatment. Poster presentation at the Annual Conference of the American thoracic Society, San Francisco CA, May 18-23, 2001.

4.  Lack of Toxicity During Concomitant Directly Observed Isoniazid and Disulfiram. Poster presentation at the Annual Conference of the American thoracic Society, San Francisco CA, May 18-23, 2001.